| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neurohypophyseal hormone activity | 3.76e-05 | 2 | 123 | 2 | GO:0005185 | |
| GeneOntologyMolecularFunction | V1A vasopressin receptor binding | 1.12e-04 | 3 | 123 | 2 | GO:0031894 | |
| GeneOntologyMolecularFunction | tRNA (guanine(10)-N2)-methyltransferase activity | 1.12e-04 | 3 | 123 | 2 | GO:0160102 | |
| GeneOntologyMolecularFunction | calcium ion binding | SLC25A24 FBLN5 DSC3 DSG3 AOAH FSTL4 ACTN1 NELL1 CELSR1 HMCN2 CELSR2 LTBP3 LTBP4 NIN | 2.13e-04 | 749 | 123 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | myo-inositol transmembrane transporter activity | 2.24e-04 | 4 | 123 | 2 | GO:0005365 | |
| GeneOntologyMolecularFunction | vasopressin receptor binding | 2.24e-04 | 4 | 123 | 2 | GO:0031893 | |
| GeneOntologyMolecularFunction | dATP binding | 3.72e-04 | 5 | 123 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 5.55e-04 | 6 | 123 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | integrin binding | 7.58e-04 | 175 | 123 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic cation channel activity | 7.75e-04 | 7 | 123 | 2 | GO:0140135 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 7.75e-04 | 7 | 123 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 7.75e-04 | 7 | 123 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 1.32e-03 | 9 | 123 | 2 | GO:0032552 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | HGF DBNL FSTL4 ETV5 SLITRK3 PLXNB2 TIAM2 TG OXT PLXNC1 PTPRZ1 AFDN WDR62 SORL1 NIN | 3.18e-06 | 625 | 119 | 15 | GO:0051960 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 HGF CCDC146 SH3GL2 DBNL FSTL4 SLITRK3 ACTN1 PLXNB2 UST ITGB3 TIAM2 HMCN2 CELSR2 P2RX7 PLXNC1 PTPRZ1 AFDN BRSK1 BRWD1 NIN | 4.35e-06 | 1194 | 119 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | EPHB6 HGF SH3GL2 DBNL FSTL4 SLITRK3 CSMD3 PLXNB2 UST TIAM2 FBXO38 HMCN2 CELSR2 HOXD10 PLXNC1 PTPRZ1 PRICKLE2 TMEM30A AFDN RPGR BRSK1 OTOG NIN | 9.13e-06 | 1463 | 119 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | HGF DBNL FSTL4 CSMD3 PLXNB2 UST TIAM2 FBXO38 PLXNC1 PTPRZ1 TMEM30A AFDN BRSK1 NIN | 1.19e-05 | 612 | 119 | 14 | GO:0010975 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB6 HGF SH3GL2 DBNL FSTL4 SLITRK3 CSMD3 PLXNB2 UST TIAM2 FBXO38 HMCN2 CELSR2 PLXNC1 PTPRZ1 PRICKLE2 TMEM30A AFDN BRSK1 OTOG NIN | 1.34e-05 | 1285 | 119 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 1.53e-05 | 9 | 119 | 3 | GO:0045924 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.58e-05 | 192 | 119 | 8 | GO:0050770 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB6 SH3GL2 DBNL FSTL4 SLITRK3 PLXNB2 UST ITGB3 TIAM2 HMCN2 CELSR2 PLXNC1 PTPRZ1 AFDN BRSK1 NIN | 2.15e-05 | 826 | 119 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | HGF DBNL FSTL4 GRIN2B CSMD3 PLXNB2 UST TIAM2 FBXO38 P2RX7 PLXNC1 PTPRZ1 TMEM30A AFDN BRSK1 NIN | 2.88e-05 | 846 | 119 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | DBNL ETV5 SLITRK3 PLXNB2 TIAM2 OXT PLXNC1 PTPRZ1 AFDN WDR62 NIN | 3.08e-05 | 418 | 119 | 11 | GO:0051962 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | HGF DBNL FSTL4 GRIN2B CSMD3 PLXNB2 UST TIAM2 FBXO38 P2RX7 PLXNC1 PTPRZ1 TMEM30A AFDN BRSK1 NIN | 3.66e-05 | 863 | 119 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | female mating behavior | 3.97e-05 | 12 | 119 | 3 | GO:0060180 | |
| GeneOntologyBiologicalProcess | synapse organization | SH3GL2 DBNL ETV5 SLITRK3 ACTN1 GRIN2B PLXNB2 ITGB3 OXT HMCN2 PLXNC1 PRICKLE2 AFDN SNTA1 | 4.12e-05 | 685 | 119 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | HGF FBLN5 DBNL FSTL4 ETV5 PLXNB2 UST ITGB3 TIAM2 CELSR1 ADAMTS9 PLXNC1 PTPRZ1 AFDN PLG BRSK1 BRWD1 NIN | 5.24e-05 | 1090 | 119 | 18 | GO:0022603 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB6 SH3GL2 DBNL FSTL4 SLITRK3 PLXNB2 UST TIAM2 HMCN2 CELSR2 PLXNC1 PTPRZ1 AFDN BRSK1 NIN | 5.92e-05 | 802 | 119 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB6 SH3GL2 DBNL FSTL4 SLITRK3 PLXNB2 UST TIAM2 HMCN2 CELSR2 PLXNC1 PTPRZ1 AFDN BRSK1 NIN | 7.49e-05 | 819 | 119 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | positive regulation of glutamate secretion | 8.10e-05 | 15 | 119 | 3 | GO:0014049 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 8.54e-05 | 313 | 119 | 9 | GO:0099173 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB6 DBNL FSTL4 SLITRK3 PLXNB2 UST TIAM2 HMCN2 CELSR2 PLXNC1 PTPRZ1 AFDN BRSK1 NIN | 1.05e-04 | 748 | 119 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB6 DBNL FSTL4 SLITRK3 PLXNB2 UST TIAM2 HMCN2 PLXNC1 PTPRZ1 BRSK1 NIN | 1.07e-04 | 566 | 119 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | HGF DBNL PLXNB2 TIAM2 FBXO38 P2RX7 PLXNC1 PTPRZ1 TMEM30A AFDN NIN | 1.37e-04 | 494 | 119 | 11 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of bone mineralization | 1.84e-04 | 91 | 119 | 5 | GO:0030500 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | DBNL FSTL4 ETV5 PLXNB2 TIAM2 PLXNC1 PTPRZ1 AFDN WDR62 SORL1 NIN | 1.97e-04 | 515 | 119 | 11 | GO:0050767 |
| GeneOntologyBiologicalProcess | positive regulation of female receptivity | 1.97e-04 | 4 | 119 | 2 | GO:0045925 | |
| GeneOntologyBiologicalProcess | maternal aggressive behavior | 1.97e-04 | 4 | 119 | 2 | GO:0002125 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 2.12e-04 | 147 | 119 | 6 | GO:0030278 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 2.15e-04 | 354 | 119 | 9 | GO:0050769 | |
| GeneOntologyBiologicalProcess | bone mineralization | 2.28e-04 | 149 | 119 | 6 | GO:0030282 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 2.31e-04 | 21 | 119 | 3 | GO:2000047 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | HGF DBNL ETV5 PLXNB2 ITGB3 TIAM2 CCN4 NELL1 RANBP3L ADAMTS9 PLXNC1 PTPRZ1 NCOA1 AFDN LTBP3 WDR62 NIN | 2.94e-04 | 1141 | 119 | 17 | GO:0045597 |
| GeneOntologyBiologicalProcess | negative regulation of protein refolding | 3.26e-04 | 5 | 119 | 2 | GO:0061084 | |
| GeneOntologyBiologicalProcess | myo-inositol transport | 3.26e-04 | 5 | 119 | 2 | GO:0015798 | |
| GeneOntologyBiologicalProcess | axon development | EPHB6 DBNL FSTL4 SLITRK3 PLXNB2 UST TIAM2 HMCN2 PLXNC1 PTPRZ1 BRSK1 NIN | 3.41e-04 | 642 | 119 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | positive regulation of amine transport | 3.51e-04 | 58 | 119 | 4 | GO:0051954 | |
| GeneOntologyBiologicalProcess | positive regulation of organic acid transport | 4.82e-04 | 63 | 119 | 4 | GO:0032892 | |
| GeneOntologyBiologicalProcess | regulation of protein refolding | 4.88e-04 | 6 | 119 | 2 | GO:0061083 | |
| GeneOntologyBiologicalProcess | regulation of glutamate secretion | 4.95e-04 | 27 | 119 | 3 | GO:0014048 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 5.23e-04 | 114 | 119 | 5 | GO:0050772 | |
| GeneOntologyBiologicalProcess | regulation of biomineral tissue development | 5.23e-04 | 114 | 119 | 5 | GO:0070167 | |
| GeneOntologyBiologicalProcess | positive regulation of bone resorption | 5.52e-04 | 28 | 119 | 3 | GO:0045780 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 6.11e-04 | 249 | 119 | 7 | GO:0010976 | |
| GeneOntologyBiologicalProcess | negative regulation of protein folding | 6.80e-04 | 7 | 119 | 2 | GO:1903333 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 7.20e-04 | 70 | 119 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 7.62e-04 | 187 | 119 | 6 | GO:0007156 | |
| GeneOntologyCellularComponent | platelet alpha granule | 2.11e-05 | 93 | 126 | 6 | GO:0031091 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 5.26e-05 | 67 | 126 | 5 | GO:0031093 | |
| GeneOntologyCellularComponent | extracellular matrix | FBLN5 COL5A3 PLXNB2 CCN4 HMCN2 ADAMTS9 PTPRZ1 AHSG LTBP3 PLG USH2A LTBP4 OTOG | 1.68e-04 | 656 | 126 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FBLN5 COL5A3 PLXNB2 CCN4 HMCN2 ADAMTS9 PTPRZ1 AHSG LTBP3 PLG USH2A LTBP4 OTOG | 1.73e-04 | 658 | 126 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | FBLN5 COL5A3 PLXNB2 HMCN2 ADAMTS9 PTPRZ1 AHSG LTBP3 PLG USH2A LTBP4 | 3.69e-04 | 530 | 126 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | secretory vesicle | HGF AVP SH3GL2 UBR4 DBNL FSTL4 TMEM63B ACTN1 GRIN2B F5 ITGB3 RNASE2 OXT AHSG TMEM30A PLG BRSK1 GP2 | 4.86e-04 | 1246 | 126 | 18 | GO:0099503 |
| GeneOntologyCellularComponent | nuclear envelope | RGPD8 RTEL1 BRAP NELL1 P2RX7 RANBP3L PHF11 PRICKLE2 TXLNG SORL1 RGPD5 | 5.84e-04 | 560 | 126 | 11 | GO:0005635 |
| Domain | Growth_fac_rcpt_ | 6.46e-07 | 156 | 118 | 9 | IPR009030 | |
| Domain | EGF_1 | HYAL4 FBLN5 ITGB3 NELL1 CELSR1 HMCN2 CELSR2 LTBP3 USH2A LTBP4 GP2 | 6.54e-07 | 255 | 118 | 11 | PS00022 |
| Domain | EGF_2 | HYAL4 FBLN5 ITGB3 NELL1 CELSR1 HMCN2 CELSR2 LTBP3 LTBP4 SORL1 GP2 | 9.55e-07 | 265 | 118 | 11 | PS01186 |
| Domain | EGF_3 | 2.44e-06 | 235 | 118 | 10 | PS50026 | |
| Domain | ASX_HYDROXYL | 3.31e-06 | 100 | 118 | 7 | PS00010 | |
| Domain | EGF-like_dom | 4.09e-06 | 249 | 118 | 10 | IPR000742 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.88e-06 | 106 | 118 | 7 | IPR000152 | |
| Domain | Laminin_G_2 | 5.10e-06 | 40 | 118 | 5 | PF02210 | |
| Domain | EGF-like_CS | 6.20e-06 | 261 | 118 | 10 | IPR013032 | |
| Domain | LamG | 8.24e-06 | 44 | 118 | 5 | SM00282 | |
| Domain | EGF_CA | 1.24e-05 | 122 | 118 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.37e-05 | 124 | 118 | 7 | IPR001881 | |
| Domain | Laminin_G | 3.24e-05 | 58 | 118 | 5 | IPR001791 | |
| Domain | Hormone_4 | 3.96e-05 | 2 | 118 | 2 | PF00220 | |
| Domain | Hormone_5 | 3.96e-05 | 2 | 118 | 2 | PF00184 | |
| Domain | NEUROHYPOPHYS_HORM | 3.96e-05 | 2 | 118 | 2 | PS00264 | |
| Domain | Neurhyp_horm | 3.96e-05 | 2 | 118 | 2 | PD001676 | |
| Domain | Neurohypophysial_hormone_CS | 3.96e-05 | 2 | 118 | 2 | IPR022423 | |
| Domain | - | 3.96e-05 | 2 | 118 | 2 | 2.60.9.10 | |
| Domain | NH | 3.96e-05 | 2 | 118 | 2 | SM00003 | |
| Domain | Ran_BP1 | 5.19e-05 | 12 | 118 | 3 | PF00638 | |
| Domain | RANBD1 | 5.19e-05 | 12 | 118 | 3 | PS50196 | |
| Domain | RanBD | 6.71e-05 | 13 | 118 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 6.71e-05 | 13 | 118 | 3 | IPR000156 | |
| Domain | fn3 | 7.64e-05 | 162 | 118 | 7 | PF00041 | |
| Domain | EGF | 1.24e-04 | 235 | 118 | 8 | SM00181 | |
| Domain | VWF_dom | 1.41e-04 | 42 | 118 | 4 | IPR001007 | |
| Domain | FN3 | 1.75e-04 | 185 | 118 | 7 | SM00060 | |
| Domain | EGF_CA | 2.14e-04 | 86 | 118 | 5 | PF07645 | |
| Domain | VWC_out | 2.21e-04 | 19 | 118 | 3 | SM00215 | |
| Domain | Neurhyp_horm | 2.36e-04 | 4 | 118 | 2 | IPR000981 | |
| Domain | TPR_1 | 2.65e-04 | 90 | 118 | 5 | IPR001440 | |
| Domain | TPR_1 | 2.65e-04 | 90 | 118 | 5 | PF00515 | |
| Domain | FN3 | 2.73e-04 | 199 | 118 | 7 | PS50853 | |
| Domain | - | 3.40e-04 | 95 | 118 | 5 | 2.60.120.200 | |
| Domain | FN3_dom | 3.67e-04 | 209 | 118 | 7 | IPR003961 | |
| Domain | EGF_Ca-bd_CS | 3.75e-04 | 97 | 118 | 5 | IPR018097 | |
| Domain | PAN_AP | 3.91e-04 | 5 | 118 | 2 | SM00473 | |
| Domain | EGF_CA | 4.12e-04 | 99 | 118 | 5 | PS01187 | |
| Domain | ConA-like_dom | 4.86e-04 | 219 | 118 | 7 | IPR013320 | |
| Domain | Ig-like_fold | EPHB6 MID2 TSPOAP1 FSTL4 PTPRU PLXNB2 MILR1 HMCN2 PLXNC1 PTPRZ1 FCRL5 USH2A SORL1 | 5.22e-04 | 706 | 118 | 13 | IPR013783 |
| Domain | VWC | 7.18e-04 | 28 | 118 | 3 | PF00093 | |
| Domain | Pan_app | 8.14e-04 | 7 | 118 | 2 | IPR003609 | |
| Domain | Desmosomal_cadherin | 8.14e-04 | 7 | 118 | 2 | IPR009122 | |
| Domain | TB | 8.14e-04 | 7 | 118 | 2 | PF00683 | |
| Domain | PAN | 8.14e-04 | 7 | 118 | 2 | PS50948 | |
| Domain | PAN_1 | 8.14e-04 | 7 | 118 | 2 | PF00024 | |
| Domain | EGF_LAM_2 | 8.81e-04 | 30 | 118 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 8.81e-04 | 30 | 118 | 3 | PS01248 | |
| Domain | - | EPHB6 MID2 TSPOAP1 FSTL4 PTPRU PLXNB2 MILR1 PLXNC1 PTPRZ1 FCRL5 USH2A SORL1 | 9.99e-04 | 663 | 118 | 12 | 2.60.40.10 |
| Domain | - | 1.08e-03 | 8 | 118 | 2 | 3.90.290.10 | |
| Domain | - | 1.26e-03 | 333 | 118 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.30e-03 | 335 | 118 | 8 | IPR015943 | |
| Domain | Plexin_cytopl | 1.38e-03 | 9 | 118 | 2 | PF08337 | |
| Domain | TB_dom | 1.38e-03 | 9 | 118 | 2 | IPR017878 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.38e-03 | 9 | 118 | 2 | IPR013548 | |
| Domain | Plexin | 1.38e-03 | 9 | 118 | 2 | IPR031148 | |
| Domain | TB | 1.38e-03 | 9 | 118 | 2 | PS51364 | |
| Domain | EGF_Lam | 1.39e-03 | 35 | 118 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.39e-03 | 35 | 118 | 3 | PF00053 | |
| Domain | VWFC_1 | 1.51e-03 | 36 | 118 | 3 | PS01208 | |
| Domain | STI1 | 1.72e-03 | 10 | 118 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 1.72e-03 | 10 | 118 | 2 | IPR006636 | |
| Domain | VWFC_2 | 1.77e-03 | 38 | 118 | 3 | PS50184 | |
| Domain | VWC | 1.77e-03 | 38 | 118 | 3 | SM00214 | |
| Domain | LAM_G_DOMAIN | 1.77e-03 | 38 | 118 | 3 | PS50025 | |
| Domain | Laminin_EGF | 1.77e-03 | 38 | 118 | 3 | IPR002049 | |
| Domain | Ephrin_rec_like | 2.10e-03 | 11 | 118 | 2 | PF07699 | |
| Domain | Grip | 2.10e-03 | 11 | 118 | 2 | SM00755 | |
| Domain | GRIP | 2.10e-03 | 11 | 118 | 2 | PF01465 | |
| Domain | NA_SOLUT_SYMP_1 | 2.10e-03 | 11 | 118 | 2 | PS00456 | |
| Domain | GAIN_dom_N | 2.10e-03 | 11 | 118 | 2 | IPR032471 | |
| Domain | GAIN | 2.10e-03 | 11 | 118 | 2 | PF16489 | |
| Domain | SSF | 2.51e-03 | 12 | 118 | 2 | PF00474 | |
| Domain | GRIP_dom | 2.51e-03 | 12 | 118 | 2 | IPR000237 | |
| Domain | GRIP | 2.51e-03 | 12 | 118 | 2 | PS50913 | |
| Domain | NA_SOLUT_SYMP_2 | 2.51e-03 | 12 | 118 | 2 | PS00457 | |
| Domain | Na/solute_symporter | 2.51e-03 | 12 | 118 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 2.51e-03 | 12 | 118 | 2 | PS50283 | |
| Domain | TPR-contain_dom | 2.64e-03 | 150 | 118 | 5 | IPR013026 | |
| Domain | PSI | 2.70e-03 | 44 | 118 | 3 | IPR016201 | |
| Domain | Unchr_dom_Cys-rich | 2.95e-03 | 13 | 118 | 2 | IPR014853 | |
| Domain | C8 | 2.95e-03 | 13 | 118 | 2 | SM00832 | |
| Domain | PSI | 3.06e-03 | 46 | 118 | 3 | SM00423 | |
| Domain | TIL_dom | 3.43e-03 | 14 | 118 | 2 | IPR002919 | |
| Domain | TPR_REGION | 3.97e-03 | 165 | 118 | 5 | PS50293 | |
| Domain | TPR | 3.97e-03 | 165 | 118 | 5 | PS50005 | |
| Domain | VWF_type-D | 4.48e-03 | 16 | 118 | 2 | IPR001846 | |
| Domain | VWFD | 4.48e-03 | 16 | 118 | 2 | PS51233 | |
| Domain | VWD | 4.48e-03 | 16 | 118 | 2 | SM00216 | |
| Domain | VWD | 4.48e-03 | 16 | 118 | 2 | PF00094 | |
| Domain | Kringle_CS | 5.06e-03 | 17 | 118 | 2 | IPR018056 | |
| Domain | KRINGLE_1 | 5.06e-03 | 17 | 118 | 2 | PS00021 | |
| Domain | KR | 5.06e-03 | 17 | 118 | 2 | SM00130 | |
| Domain | Kringle | 5.06e-03 | 17 | 118 | 2 | IPR000001 | |
| Domain | KRINGLE_2 | 5.06e-03 | 17 | 118 | 2 | PS50070 | |
| Domain | Kringle | 5.06e-03 | 17 | 118 | 2 | PF00051 | |
| Domain | Cadherin_CS | 5.06e-03 | 109 | 118 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 5.75e-03 | 113 | 118 | 4 | PS00232 | |
| Domain | Cadherin | 5.75e-03 | 113 | 118 | 4 | PF00028 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.42e-05 | 8 | 91 | 3 | M47850 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.09e-05 | 32 | 91 | 4 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.12e-05 | 37 | 91 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.12e-04 | 39 | 91 | 4 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.81e-04 | 44 | 91 | 4 | M26969 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 1.92e-04 | 130 | 91 | 6 | MM15455 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 2.09e-04 | 132 | 91 | 6 | M724 | |
| Pubmed | 1.16e-08 | 21 | 127 | 5 | 16079250 | ||
| Pubmed | 1.34e-06 | 215 | 127 | 8 | 35973513 | ||
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 1.65e-06 | 7 | 127 | 3 | 17937400 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MPP3 UBR4 TRMT11 ATG2A PLXNB2 TIAM2 SBNO2 NBPF1 ORC1 CELSR1 PNPLA6 RPAP1 CELSR2 LTBP3 LTBP4 ABCC10 | 2.91e-06 | 1105 | 127 | 16 | 35748872 |
| Pubmed | Proteomic and functional evidence for a P2X7 receptor signalling complex. | 7.68e-06 | 11 | 127 | 3 | 11707406 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 2991279 | ||
| Pubmed | Control of lung development by latent TGF-β binding proteins. | 1.32e-05 | 2 | 127 | 2 | 20945348 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 29609987 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 21887366 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 8863731 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23570448 | ||
| Pubmed | Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage. | 1.32e-05 | 2 | 127 | 2 | 24412107 | |
| Pubmed | Synthesis, transport, and release of posterior pituitary hormones. | 1.32e-05 | 2 | 127 | 2 | 6153132 | |
| Pubmed | The contributions of oxytocin and vasopressin pathway genes to human behavior. | 1.32e-05 | 2 | 127 | 2 | 22245314 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 24086383 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 31538678 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 21899794 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23292348 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20144509 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 12944509 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19500216 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19120108 | ||
| Pubmed | Ontogeny of the vasopressin and oxytocin RNAs in the mouse hypothalamus. | 1.32e-05 | 2 | 127 | 2 | 9678638 | |
| Pubmed | Sociality, pathogen avoidance, and the neuropeptides oxytocin and arginine vasopressin. | 1.32e-05 | 2 | 127 | 2 | 21960250 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19672816 | ||
| Pubmed | St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis. | 1.32e-05 | 2 | 127 | 2 | 35562743 | |
| Pubmed | Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons. | 1.32e-05 | 2 | 127 | 2 | 22262306 | |
| Pubmed | Somatic mutations and germline sequence variants in patients with familial colorectal cancer. | 1.32e-05 | 2 | 127 | 2 | 21351276 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 3768139 | ||
| Pubmed | Expression of the vasopressin and oxytocin genes in human hypothalami. | 1.32e-05 | 2 | 127 | 2 | 4065330 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 17846785 | ||
| Pubmed | Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions. | 1.32e-05 | 2 | 127 | 2 | 23589638 | |
| Pubmed | [Oxytocin and vasopressin: sexual differences and clinical implications]. | 1.32e-05 | 2 | 127 | 2 | 37200960 | |
| Pubmed | Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. | 1.32e-05 | 2 | 127 | 2 | 23382201 | |
| Pubmed | On the nature of oxytocin and vasopressin from human pituitary. | 1.32e-05 | 2 | 127 | 2 | 13591312 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23403283 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 14962074 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 36113782 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 36979340 | ||
| Pubmed | Identification of human neurophysins: complete amino acid sequences of MSEL- and VLDV-neurophysins. | 1.32e-05 | 2 | 127 | 2 | 6574452 | |
| Pubmed | Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. | 1.32e-05 | 2 | 127 | 2 | 19032932 | |
| Pubmed | 1.32e-05 | 13 | 127 | 3 | 26989192 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 2.19e-05 | 153 | 127 | 6 | 26365490 | |
| Pubmed | 2.57e-05 | 16 | 127 | 3 | 17356169 | ||
| Pubmed | 3.58e-05 | 167 | 127 | 6 | 22159717 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 39034759 | ||
| Pubmed | Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse. | 3.96e-05 | 3 | 127 | 2 | 29729708 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 28715127 | ||
| Pubmed | [Occurrence of plasmic and platelet prothrombotic polymorphisms in women in childbirth]. | 3.96e-05 | 3 | 127 | 2 | 16875034 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 11677057 | ||
| Pubmed | Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. | 3.96e-05 | 3 | 127 | 2 | 22829427 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 25713297 | ||
| Pubmed | α-Syntrophin is required for the hepatocyte growth factor-induced migration of cultured myoblasts. | 3.96e-05 | 3 | 127 | 2 | 22001117 | |
| Pubmed | Overestimation of genetic risks owing to small sample sizes in cardiovascular studies. | 3.96e-05 | 3 | 127 | 2 | 12791034 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 22564531 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 19348003 | ||
| Pubmed | Specification of oxytocinergic and vasopressinergic circuits in the developing mouse brain. | 3.96e-05 | 3 | 127 | 2 | 33990685 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 25863961 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 17015624 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 2176709 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 19230252 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 25237006 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 12531518 | ||
| Pubmed | 4.01e-05 | 52 | 127 | 4 | 19328558 | ||
| Pubmed | 4.65e-05 | 175 | 127 | 6 | 28071719 | ||
| Pubmed | 5.18e-05 | 20 | 127 | 3 | 11438667 | ||
| Pubmed | 7.55e-05 | 118 | 127 | 5 | 21078624 | ||
| Pubmed | A distinct hypothalamus-to-β cell circuit modulates insulin secretion. | 7.90e-05 | 4 | 127 | 2 | 35108515 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 15611103 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 19824427 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 23161541 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 19461049 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 31371721 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 20175210 | ||
| Pubmed | Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage. | 7.90e-05 | 4 | 127 | 2 | 12738509 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 11089561 | ||
| Pubmed | Genetic and acquired prothrombotic risk factors and sudden hearing loss. | 7.90e-05 | 4 | 127 | 2 | 17334320 | |
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 7.90e-05 | 4 | 127 | 2 | 37224017 | |
| Pubmed | Plasmin-mediated processing of protein tyrosine phosphatase receptor type Z in the mouse brain. | 7.90e-05 | 4 | 127 | 2 | 18647637 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 15166939 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 33780330 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 7.90e-05 | 4 | 127 | 2 | 11104663 | |
| Pubmed | Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease. | 7.90e-05 | 4 | 127 | 2 | 19959486 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 23515331 | ||
| Pubmed | An interaction between alpha-actinin and the beta 1 integrin subunit in vitro. | 7.90e-05 | 4 | 127 | 2 | 2116421 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 19336355 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 17290027 | ||
| Pubmed | Modulation of clinical phenotype of Glanzmann's thrombasthenia by thrombogenic mutations. | 7.90e-05 | 4 | 127 | 2 | 19245802 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 20092567 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 26261166 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 22079582 | ||
| Pubmed | ADIP, a novel Afadin- and alpha-actinin-binding protein localized at cell-cell adherens junctions. | 7.90e-05 | 4 | 127 | 2 | 12446711 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 9480752 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 19374152 | ||
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 7.90e-05 | 4 | 127 | 2 | 11850187 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 11279932 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 28935705 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 16157329 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 15676177 | ||
| Pubmed | Antigens recognized by autologous antibody in patients with renal-cell carcinoma. | 8.55e-05 | 63 | 127 | 4 | 10508479 | |
| Cytoband | 7q31.3 | 9.18e-06 | 15 | 127 | 3 | 7q31.3 | |
| Cytoband | 14q24 | 4.11e-04 | 11 | 127 | 2 | 14q24 | |
| Cytoband | 11p15.1 | 6.30e-04 | 60 | 127 | 3 | 11p15.1 | |
| Cytoband | 3p14.1 | 2.01e-03 | 24 | 127 | 2 | 3p14.1 | |
| Cytoband | 12q24 | 2.18e-03 | 25 | 127 | 2 | 12q24 | |
| Cytoband | 18q12.1 | 2.36e-03 | 26 | 127 | 2 | 18q12.1 | |
| Cytoband | 20q11.2 | 2.55e-03 | 27 | 127 | 2 | 20q11.2 | |
| GeneFamily | Neuroblastoma breakpoint family | 7.22e-08 | 23 | 87 | 5 | 662 | |
| GeneFamily | Fibronectin type III domain containing | 1.20e-05 | 160 | 87 | 7 | 555 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 6.85e-05 | 3 | 87 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 6.85e-05 | 3 | 87 | 2 | 1189 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.36e-04 | 4 | 87 | 2 | 628 | |
| GeneFamily | Desmosomal cadherins | 4.73e-04 | 7 | 87 | 2 | 1188 | |
| GeneFamily | Fibulins | 6.29e-04 | 8 | 87 | 2 | 556 | |
| GeneFamily | Plexins | 8.06e-04 | 9 | 87 | 2 | 683 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.53e-03 | 21 | 87 | 2 | 813 | |
| GeneFamily | PDZ domain containing | 6.23e-03 | 152 | 87 | 4 | 1220 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.04e-07 | 196 | 127 | 9 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 9.76e-07 | 275 | 127 | 10 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.39e-06 | 191 | 127 | 8 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 7.03e-06 | 270 | 127 | 9 | MM17057 | |
| Coexpression | NABA_MATRISOME | HYAL4 HGF FBLN5 KCP COL5A3 PLXNB2 CCN4 NELL1 HMCN2 ADAMTS9 PLXNC1 LTBP3 PLG USH2A LTBP4 OTOG | 3.76e-05 | 1026 | 127 | 16 | M5889 |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-07 | 166 | 125 | 7 | 3b67064a5149e72f895344d938c64b8ff65247f5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-06 | 190 | 125 | 7 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-06 | 195 | 125 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 197 | 125 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 197 | 125 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.58e-06 | 200 | 125 | 7 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.58e-06 | 200 | 125 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-06 | 170 | 125 | 6 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 175 | 125 | 6 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 177 | 125 | 6 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 177 | 125 | 6 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 180 | 125 | 6 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 182 | 125 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 182 | 125 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 184 | 125 | 6 | 9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.39e-05 | 185 | 125 | 6 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 187 | 125 | 6 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 188 | 125 | 6 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 188 | 125 | 6 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-05 | 189 | 125 | 6 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-05 | 190 | 125 | 6 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-05 | 190 | 125 | 6 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-05 | 190 | 125 | 6 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 191 | 125 | 6 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 191 | 125 | 6 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.72e-05 | 192 | 125 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 193 | 125 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 193 | 125 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-05 | 194 | 125 | 6 | 11ff53a748160570d2908ea9eb9779c038e5b676 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-05 | 197 | 125 | 6 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 199 | 125 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.10e-05 | 199 | 125 | 6 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.10e-05 | 199 | 125 | 6 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.10e-05 | 199 | 125 | 6 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.10e-05 | 199 | 125 | 6 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-05 | 200 | 125 | 6 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.16e-05 | 200 | 125 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | d92d51021ab6d78e9c8f89f7c150181004dcbcbd | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.16e-05 | 200 | 125 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | cbbb9044283ff9ab63bbfc24d7a9f006b1372705 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-05 | 200 | 125 | 6 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 2.16e-05 | 200 | 125 | 6 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.16e-05 | 200 | 125 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-05 | 200 | 125 | 6 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | a3e36bbeed19431d07bc205f14f4e0f12bd8f730 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Basal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.16e-05 | 200 | 125 | 6 | 7098ae4b0ea8ba607519eaed8577c577530fc2a1 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-05 | 200 | 125 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.44e-05 | 131 | 125 | 5 | 1823cab28fab40486247ca92104267b1e370bdc1 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.97e-05 | 135 | 125 | 5 | 7743a01dc9c4542e910e7c0fe046004692a680bf | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 150 | 125 | 5 | 98fdc6bdfde84d680e11d8727502b79afbf64303 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.19e-05 | 153 | 125 | 5 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.19e-05 | 153 | 125 | 5 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.42e-05 | 154 | 125 | 5 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Sst_(Reticular_formation)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.01e-05 | 81 | 125 | 4 | 717751c7a6af08cec7d0e561869e4b292d1f83a5 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Sst_(Reticular_formation)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.01e-05 | 81 | 125 | 4 | e58f07266b7bad0af9a9856c678b4e0850c9f6c9 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-05 | 164 | 125 | 5 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 168 | 125 | 5 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | 573f85075d83a4baba41c3e24dc4d9831823a5e5 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | a24d12199b1a6d9cb243b3a68f4109d3a30b2dcb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 169 | 125 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 170 | 125 | 5 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 170 | 125 | 5 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 172 | 125 | 5 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 172 | 125 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 172 | 125 | 5 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 172 | 125 | 5 | 3c0bf7200e582ee730af49dcd86446e112226aca | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 176 | 125 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 176 | 125 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-04 | 177 | 125 | 5 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.46e-04 | 178 | 125 | 5 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 178 | 125 | 5 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 178 | 125 | 5 | ef490b45901b2e6dedb519540fa3ae4e4db3a9ba | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-04 | 178 | 125 | 5 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 180 | 125 | 5 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.62e-04 | 182 | 125 | 5 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 182 | 125 | 5 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 182 | 125 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 182 | 125 | 5 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 182 | 125 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 183 | 125 | 5 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 183 | 125 | 5 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 183 | 125 | 5 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 184 | 125 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-04 | 185 | 125 | 5 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 185 | 125 | 5 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 185 | 125 | 5 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | 2f103ce2427f9cf2c1fafb6bd6045c5863a47549 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 186 | 125 | 5 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 186 | 125 | 5 | 55b239834b96b1f7787ec77a7d19796d617bbbf0 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 186 | 125 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-04 | 187 | 125 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| Drug | AC1L45X9 | 1.58e-07 | 3 | 124 | 3 | CID000151233 | |
| Drug | Z-PLG | 6.28e-07 | 4 | 124 | 3 | CID000151917 | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.14e-05 | 194 | 124 | 8 | 2900_DN | |
| Drug | Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.27e-05 | 197 | 124 | 8 | 6779_UP | |
| Drug | pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid | 1.29e-05 | 9 | 124 | 3 | ctd:C077792 | |
| Drug | Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.32e-05 | 198 | 124 | 8 | 3505_UP | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.37e-05 | 199 | 124 | 8 | 6491_UP | |
| Drug | AC1NURZQ | 2.94e-05 | 2 | 124 | 2 | CID005490952 | |
| Drug | 2-phenylalanine | 2.94e-05 | 2 | 124 | 2 | CID000031722 | |
| Drug | Cgp 29325 | 2.94e-05 | 2 | 124 | 2 | CID000175772 | |
| Drug | Glumitocin | 2.94e-05 | 2 | 124 | 2 | CID003084054 | |
| Drug | Demoxytocin | 2.94e-05 | 2 | 124 | 2 | CID000008229 | |
| Drug | P9-28 | 2.94e-05 | 2 | 124 | 2 | CID000139428 | |
| Drug | Pro-arg-gly-amide | 2.94e-05 | 2 | 124 | 2 | CID000170777 | |
| Drug | 5-carboxymethyluridine | 2.94e-05 | 2 | 124 | 2 | CID003080720 | |
| Drug | Phasvatocin | 2.94e-05 | 2 | 124 | 2 | CID000192334 | |
| Drug | ethyl cyclohexylideneacetate | 2.94e-05 | 2 | 124 | 2 | CID000073776 | |
| Drug | Utedrin | 5.49e-05 | 14 | 124 | 3 | CID000005771 | |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 8.07e-05 | 189 | 124 | 7 | 882_UP | |
| Drug | ranatensin C | 8.80e-05 | 3 | 124 | 2 | CID005488559 | |
| Drug | Annetocin | 8.80e-05 | 3 | 124 | 2 | CID000197651 | |
| Drug | L 366682 | 8.80e-05 | 3 | 124 | 2 | CID000196819 | |
| Drug | phorbol 13,20-diacetate | 8.80e-05 | 3 | 124 | 2 | CID000162041 | |
| Drug | AC1O4Q3H | 8.80e-05 | 3 | 124 | 2 | CID006410744 | |
| Drug | L 366811 | 8.80e-05 | 3 | 124 | 2 | CID003083084 | |
| Drug | dE-Vvt | 8.80e-05 | 3 | 124 | 2 | CID003083171 | |
| Drug | AC1L9Q7N | 8.80e-05 | 3 | 124 | 2 | CID000452294 | |
| Drug | Dglvp | 8.80e-05 | 3 | 124 | 2 | CID000169434 | |
| Drug | Asvatocin | 8.80e-05 | 3 | 124 | 2 | CID000192333 | |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 8.91e-05 | 192 | 124 | 7 | 6513_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.51e-05 | 194 | 124 | 7 | 4219_DN | |
| Drug | NSC233046 | 9.67e-05 | 84 | 124 | 5 | CID000005277 | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 4162_UP | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 3199_UP | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 2276_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 3837_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 3639_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 2532_DN | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; HL60; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 3104_UP | |
| Disease | Dysmenorrhea | 1.56e-05 | 2 | 117 | 2 | C0013390 | |
| Disease | Respiratory Tract Infections | 4.66e-05 | 3 | 117 | 2 | C0035243 | |
| Disease | Upper Respiratory Infections | 4.66e-05 | 3 | 117 | 2 | C0041912 | |
| Disease | cutis laxa (implicated_via_orthology) | 4.66e-05 | 3 | 117 | 2 | DOID:3144 (implicated_via_orthology) | |
| Disease | Hyponatremia | 9.30e-05 | 4 | 117 | 2 | C0020625 | |
| Disease | hepatitis (biomarker_via_orthology) | 9.30e-05 | 4 | 117 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 1.55e-04 | 5 | 117 | 2 | DOID:0050864 (is_implicated_in) | |
| Disease | Polyuria | 1.55e-04 | 5 | 117 | 2 | C0032617 | |
| Disease | Cutis Laxa | 2.31e-04 | 6 | 117 | 2 | C0010495 | |
| Disease | oxytocin-neurophysin 1 measurement | 2.31e-04 | 6 | 117 | 2 | EFO_0802839 | |
| Disease | Autosomal dominant macrothrombocytopenia | 3.23e-04 | 7 | 117 | 2 | C4304021 | |
| Disease | smoking status measurement, high density lipoprotein cholesterol measurement | 3.23e-04 | 7 | 117 | 2 | EFO_0004612, EFO_0006527 | |
| Disease | Borderline personality disorder | 3.62e-04 | 35 | 117 | 3 | HP_0012076 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.88e-04 | 86 | 117 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | NRF2 measurement | 4.30e-04 | 8 | 117 | 2 | EFO_0009794 | |
| Disease | autoimmune disease | 6.45e-04 | 173 | 117 | 5 | EFO_0005140 | |
| Disease | Tetralogy of Fallot | 6.87e-04 | 10 | 117 | 2 | HP_0001636 | |
| Disease | macrovascular complications of diabetes | 6.87e-04 | 10 | 117 | 2 | EFO_0010977 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 6.87e-04 | 10 | 117 | 2 | EFO_0008321 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 8.68e-04 | 47 | 117 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | Pain, Migratory | 9.80e-04 | 49 | 117 | 3 | C0751407 | |
| Disease | Suffering, Physical | 9.80e-04 | 49 | 117 | 3 | C0751408 | |
| Disease | Pain, Crushing | 9.80e-04 | 49 | 117 | 3 | C0458259 | |
| Disease | Pain, Splitting | 9.80e-04 | 49 | 117 | 3 | C0458257 | |
| Disease | Pain | 9.80e-04 | 49 | 117 | 3 | C0030193 | |
| Disease | Radiating pain | 9.80e-04 | 49 | 117 | 3 | C0234254 | |
| Disease | Pain, Burning | 9.80e-04 | 49 | 117 | 3 | C0234230 | |
| Disease | Ache | 9.80e-04 | 49 | 117 | 3 | C0234238 | |
| Disease | Hypotension | 1.23e-03 | 53 | 117 | 3 | C0020649 | |
| Disease | reaction time measurement | 1.26e-03 | 658 | 117 | 9 | EFO_0008393 | |
| Disease | peripheral arterial disease | 1.30e-03 | 54 | 117 | 3 | EFO_0004265 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 1.45e-03 | 56 | 117 | 3 | EFO_0022250 | |
| Disease | cancer biomarker measurement | 1.58e-03 | 15 | 117 | 2 | EFO_0005127 | |
| Disease | Graves' disease (is_marker_for) | 1.58e-03 | 15 | 117 | 2 | DOID:12361 (is_marker_for) | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.68e-03 | 59 | 117 | 3 | EFO_0022289 | |
| Disease | Neoplasm Metastasis | 1.77e-03 | 217 | 117 | 5 | C0027627 | |
| Disease | free cholesterol in IDL measurement | 1.85e-03 | 61 | 117 | 3 | EFO_0022181 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.03e-03 | 63 | 117 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.03e-03 | 63 | 117 | 3 | EFO_0022239 | |
| Disease | Vascular Diseases | 2.04e-03 | 17 | 117 | 2 | C0042373 | |
| Disease | total lipids in small VLDL | 2.42e-03 | 67 | 117 | 3 | EFO_0022148 | |
| Disease | free cholesterol in large VLDL measurement | 2.52e-03 | 68 | 117 | 3 | EFO_0022265 | |
| Disease | opioid dependence | 2.59e-03 | 237 | 117 | 5 | EFO_0005611 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.68e-03 | 239 | 117 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | Schizophrenia | 2.74e-03 | 883 | 117 | 10 | C0036341 | |
| Disease | alpha-tocopherol measurement | 2.83e-03 | 20 | 117 | 2 | EFO_0007898 | |
| Disease | Bipolar Disorder | 2.98e-03 | 477 | 117 | 7 | C0005586 | |
| Disease | stroke, coronary artery disease | 3.12e-03 | 21 | 117 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | Deep Vein Thrombosis | 3.12e-03 | 21 | 117 | 2 | C0149871 | |
| Disease | Obsessive-compulsive trait | 3.12e-03 | 21 | 117 | 2 | HP_0008770 | |
| Disease | Venous Thrombosis | 3.12e-03 | 21 | 117 | 2 | C0042487 | |
| Disease | urate measurement, bone density | 3.31e-03 | 619 | 117 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 3.33e-03 | 75 | 117 | 3 | EFO_0022287 | |
| Disease | parental longevity | 3.61e-03 | 494 | 117 | 7 | EFO_0007796 | |
| Disease | Malignant neoplasm of breast | CTU2 DSC3 UBR4 TRMT11 ALS2CL PER3 AFP NCOA1 FCRL5 SORL1 ZNF646 | 3.66e-03 | 1074 | 117 | 11 | C0006142 |
| Disease | Lung diseases | 3.72e-03 | 78 | 117 | 3 | C0024115 | |
| Disease | peak expiratory flow | 3.77e-03 | 498 | 117 | 7 | EFO_0009718 | |
| Disease | Unipolar Depression | 3.78e-03 | 259 | 117 | 5 | C0041696 | |
| Disease | very low density lipoprotein cholesterol measurement | 3.84e-03 | 260 | 117 | 5 | EFO_0008317 | |
| Disease | Autistic Disorder | 3.91e-03 | 261 | 117 | 5 | C0004352 | |
| Disease | Endometrioma | 3.93e-03 | 161 | 117 | 4 | C0269102 | |
| Disease | Endometriosis | 3.93e-03 | 161 | 117 | 4 | C0014175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DKYAPDDIPNINSTC | 856 | P55196 | |
| PEDGYSCDVVRNIPN | 936 | P55196 | |
| QPPDCRCAEYTFQAE | 336 | Q60I27 | |
| FLEREPLCYQEGNNP | 271 | P0C875 | |
| PVCRYCQTPEPVEEN | 301 | Q7Z569 | |
| DELRRELPPDQAEYC | 846 | P12814 | |
| NITFSEYNLEPCEDP | 1171 | Q7Z407 | |
| AQAIFNELPCEYVEP | 231 | Q9UDR5 | |
| DAPIRCVEYCPEVNV | 96 | O43684 | |
| ICSNALEYNPDRDPG | 1056 | Q6PL18 | |
| CRNPNDIFADLESYP | 346 | O95388 | |
| TYNNPVRDRECQTEP | 201 | Q9UI46 | |
| PFDDNICLREPCENY | 1301 | Q9NYQ6 | |
| PFDDNICLREPCENY | 1226 | Q9HCU4 | |
| DPQDPSPDAYCNLVI | 291 | Q9NUG4 | |
| QRLEYCDEAVRDPSQ | 196 | Q2TAZ0 | |
| PLACNLCYEAESPDE | 716 | Q9P241 | |
| CDRAIEINPDSAQPY | 171 | Q8NFI4 | |
| CDRAIEINPDSAQPY | 171 | P50502 | |
| VPNESCYPSRSEEEL | 1061 | Q09MP3 | |
| LEPSVEEARYNSCRP | 196 | P43351 | |
| FNPEEINLDCTNPRY | 171 | Q5HYI8 | |
| NDALSPEEQEECRNY | 696 | Q99666 | |
| NDALSPEEQEECRNY | 696 | O14715 | |
| PACQRPEDEEVEAFL | 96 | O95153 | |
| YLETQNPALPCVEFD | 96 | Q9NRN5 | |
| NIEECSEDEYPPLFL | 156 | Q5JPF3 | |
| CNDSDESVYPGRRPN | 206 | P28039 | |
| PSNIICDQDLSNYDP | 1601 | Q8N7Z5 | |
| VYVRVPDFNDNCPTA | 481 | P32926 | |
| ERLEEYTCDLPQEPQ | 1216 | Q5T3U5 | |
| TQEPREQPAGACEYS | 466 | Q8IY17 | |
| VAPEDQAPYVCEARN | 851 | Q8NDA2 | |
| VPCDKPFSEEQARLY | 241 | Q8N5S9 | |
| RNTPIEALCENFPEE | 271 | Q9HCP0 | |
| PCEDLRNDEHSPSYQ | 521 | P56645 | |
| LRYHECREASPNPED | 641 | O15031 | |
| ACDPSDYERNQEQCP | 621 | O60486 | |
| PDNILEVQESGEYRC | 71 | Q96RD9 | |
| DPCQNYTLLDEPFRS | 61 | P55259 | |
| PRDYCVDSEVPNCQS | 296 | P41161 | |
| IPEDYCPLDVQIPSD | 236 | Q9NVC6 | |
| TSNPEVRYEVCDIPQ | 191 | P14210 | |
| CSSEPENVQADPENY | 311 | P23471 | |
| YQEVEEDQDPSCPRL | 951 | Q3BBV0 | |
| YIPAFCELPLDDQVA | 156 | Q14541 | |
| DCNRIYERVIDPPDT | 166 | Q92832 | |
| PVFQEVAPREQEACD | 316 | Q7Z6M3 | |
| EASDPAVPCEYSQAQ | 31 | Q92729 | |
| PPHDNEVRYCNSLDE | 81 | Q7Z3G6 | |
| NFCVVELLPSDPEYN | 1616 | Q460N5 | |
| PESLPCREQEFQDIY | 501 | Q13415 | |
| QPESCDVQSNEDYPR | 851 | Q6PIJ6 | |
| QRIQEEECPPRDDFS | 206 | Q9NV92 | |
| TEGQEQRLCPEYPTR | 111 | Q99572 | |
| ECNPYTRPESERDCQ | 1536 | Q9P2N4 | |
| PVDRESCSLQPCEYV | 1601 | Q9P2N4 | |
| DEGPECTPAAQYVRI | 466 | Q14574 | |
| NDNPPEILQEYVVIC | 571 | Q14574 | |
| IYRQPNCDDPETEEA | 26 | P02765 | |
| YEEICPQREKNATQP | 486 | Q6MZW2 | |
| EEAYPNCTVLEARPC | 261 | Q5T3F8 | |
| PNYSGSCPEDEVLRN | 231 | Q2M3T9 | |
| YQRLVPESCPVENPE | 131 | P28358 | |
| YPSCEDQDLPPRNDV | 361 | Q8TDC3 | |
| QCEDSEPFRQPVDLV | 1331 | Q9NSI6 | |
| LNPSKECEPYRRNED | 151 | Q9NV96 | |
| AEYSPAQRQCLSPEE | 1066 | Q9NS15 | |
| DDFEALCNVLRPPAY | 1396 | Q8N2S1 | |
| EEDYRPSQQDECSPR | 501 | P05106 | |
| EPLYEEPCNEISKEQ | 951 | Q9HC35 | |
| RFTVENEDLDVAPCP | 221 | Q8NDH2 | |
| DPIRCEEPYLRISDN | 316 | Q9UBX5 | |
| RPCFYDIDLDPETEQ | 916 | P11586 | |
| ISPDPQAAFQACERY | 206 | P25940 | |
| REDPQACIEEQLCYS | 451 | Q2VPK5 | |
| TPPCLVQAEEEAVYE | 321 | Q9UJU6 | |
| VPEPVTSCEAYEEDR | 141 | P02771 | |
| VYEQCEALLRPPFDA | 346 | Q6ZRI0 | |
| HYNPREDRAIPCQEA | 236 | Q13368 | |
| ANLEERAICEYNENP | 906 | Q92834 | |
| DPESSLCVEYEQEPV | 811 | Q9NZ71 | |
| CYRQPEDADTGEEPL | 341 | Q9BST9 | |
| YARILPGEVCCPDEQ | 3241 | O75445 | |
| DCDRAIEINPDSAQP | 166 | Q8IZP2 | |
| PCPLAEENEFILYAV | 751 | Q92673 | |
| VLEDYGLDPNCIPEN | 151 | Q7Z4G4 | |
| EADTDVQVCPNYSIP | 231 | Q7Z2T5 | |
| PEPRYLEICSADGQD | 231 | Q13424 | |
| DEPTENDAQCLTRPY | 491 | P12259 | |
| QEPDCSLEAQPKYVR | 86 | Q8N4C6 | |
| KYQEVEEDQDPSCPR | 1411 | Q6P3W6 | |
| YQEVEEDQDPSCPRL | 1656 | Q6P3W6 | |
| KYQEVEEDQDPSCPR | 2631 | Q6P3W6 | |
| YQEVEEDQDPSCPRL | 2876 | Q6P3W6 | |
| YQEVEEDQDPSCPRL | 951 | Q5TAG4 | |
| KYQEVEEDQDPSCPR | 896 | A0A087WUL8 | |
| YQEVEEDQDPSCPRL | 1141 | A0A087WUL8 | |
| KYQEVEEDQDPSCPR | 2116 | A0A087WUL8 | |
| YQEVEEDQDPSCPRL | 2361 | A0A087WUL8 | |
| EPEVLQDPLDRCYST | 3116 | A0A087WUL8 | |
| KYQEVEEDQDPSCPR | 3336 | A0A087WUL8 | |
| YQEVEEDQDPSCPRL | 3581 | A0A087WUL8 | |
| KYQEVEEDQDPSCPR | 796 | P0DPF2 | |
| YQEVEEDQDPSCPRL | 1041 | P0DPF2 | |
| KYQEVEEDQDPSCPR | 2016 | P0DPF2 | |
| YQEVEEDQDPSCPRL | 2261 | P0DPF2 | |
| KYQEVEEDQDPSCPR | 3236 | P0DPF2 | |
| YQEVEEDQDPSCPRL | 3481 | P0DPF2 | |
| YQEVEEDQDPSCPRL | 4701 | P0DPF2 | |
| YLSNQEFPDPREPCN | 791 | Q6ZWJ8 | |
| EPGTENQEACQRYEV | 206 | Q15788 | |
| EALRCQEENYLPSPC | 71 | P01178 | |
| IDPSTYEDPCQAIRE | 646 | O15197 | |
| ARSPEAPAYRLQDCD | 36 | O43930 | |
| CNNPIYKPREEEEVA | 751 | O94933 | |
| ILAFAYRAPECDQPD | 486 | P53794 | |
| VLDFIYVQPRCDQPD | 496 | Q8WWX8 | |
| EEIPLAPAFECVYNR | 491 | Q9Y2G9 | |
| GCNFPEYELPELNTR | 26 | Q92966 | |
| GLEENYCRNPDNDPQ | 146 | P00747 | |
| VACDNRDQRRDPPQY | 136 | P10153 | |
| AEQRPNAYIPEADAT | 906 | Q8IYE0 | |
| ECILENYPECSNPRL | 231 | Q9Y2C2 | |
| VPAEDCSEPVQLLRY | 186 | Q8IVF5 | |
| PEAFRDTQPEQCREA | 201 | Q9BW04 | |
| DQPCCRALYDFEPEN | 291 | Q99962 | |
| RPAEDTLYEAAEPEC | 51 | Q86VV4 | |
| EALRCQEENYLPSPC | 71 | P01185 | |
| PVFEEAPVELRCNYS | 31 | A0A0B4J262 | |
| QDSEEADSIPRPYRC | 36 | O15015 | |
| IEPLGYCEDAESNRQ | 396 | Q92576 | |
| ACPRPEDNDLYDAIT | 141 | A6NKC9 | |
| CEDQDPLNPDRSFDV | 81 | Q9UIL8 | |
| ECYTVPPEDNLALLQ | 1271 | Q9BWH6 | |
| EVYPEFEDQRACLPS | 411 | O43379 | |
| NFNCISETERPEDPA | 366 | Q6ZSB9 | |
| APDFIDYPERQECNC | 706 | Q9UJV3 | |
| DYPERQECNCRPQES | 711 | Q9UJV3 | |
| VSPAYCTQESREEIP | 96 | Q9NUQ3 | |
| YLESDPCLVCNNPEV | 3526 | Q5T4S7 | |
| CQDESIYKTEPRPEA | 276 | Q92547 | |
| IFEYQVDAQPLRPCE | 21 | P01266 | |
| PTAACQDAEQPTRYE | 11 | Q6NUK1 | |
| YEEVSQPCQEVPDIS | 1251 | Q6PFW1 | |
| EVQTRCPFILPDNDE | 336 | B1AL88 | |
| NPPCEENLFSDYISE | 951 | Q13224 |